PSEUDARTHROSIS SUPRASPINATUS TENDON RUPTURE
Conditions
Interventions
Group 1: This study gives an overview of current musculoskeletal CEUS (contrast-enhanced ultrasound) applications and investigated the incidence of adverse events (AEs) in this particular cohort.
Sponsors
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Data of study patients, who underwent musculoskeletal CEUS examinations with SonoVue® between 2012 and 2019, were included.
Exclusion criteria
Exclusion criteria: Exclusion criteria for the utilization of CEUS were a history of recent myocardial infarction, an intracardial right-left shunt, uncontrollable fluctuations of blood pressure, severe respiratory disease (pulmonary arterial hypertension (PAH), severe acute respiratory syndrome (SARS), during pregnancy and while breast-feeding (missing studies, no evidence) or any known allergic reaction to SonoVue® as well as other similar contrast agents. Further exclusion criteria were an age younger than 18 years and the lack of the patients’ informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse Events of every application of SonoVue® | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of severe adverse Events of every application of SonoVue® | — |
Countries
Germany
Contacts
Public ContactJulian Doll
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Outcome results
None listed